OncoReview 2, June 2018
as tradition has it, the following issue of “OnCOReview” includes papers which advance our knowledge on cardiooncology, haematology and oncological endocrinology as well as present practical experience gained in the course of interdisciplinary treatment of “difficult” patients.
In the section dedicated to cardiooncology, you will find a description of surgical treatment in a patient with ovarian tumour. The case would not have raised so much interest, had it not been for the fact that the patient had a severe cardiac history, being born with a congenital heart defect, requiring a later pacemaker implantation. Taking decision on performing an oncological surgery in such cases always involves a detailed assessment of the cardiovascular risk at stake. The key to success lies in interdisciplinary cooperation.
The haematology section contains a very interesting case study which focuses on the treatment of abdominal-cardiac-pulmonary invasive aspergillosis. Such clinical situations are few and far between, and we have very limited data on the practical management to be recommended. It is worth paying attention to the treatment algorithm proposed by the authors. Their experiences may prove extremely helpful at any department of haematology.
First of the two papers dedicated to endocrinology discuss the differences and difficulties related to the diagnostics and treatment of pNET in patients with MEN1. The subject matter is important in tha the best results may only be accomplished thanks to an early implementation of efficacious treatment methods. Another article sheds light on the diagnostics and treatment of Nelson’s syndrome, a rare disease that develops after bilateral adrenalectomy for Cushing’s disease.
Finally, the issue is crowned by a quality of life analysis. This time it focuses on the quality of life as experienced by breast cancer patients after treatment.
Editor-in-Chief Deputy Editor-in-Chief
Sebastian Szmit, MD, PhD Eric E. Harrison, MD
Assistant Professor Associate Professor
Fellow of ACC, AHA, ASAI, ACP